Inhibitory activity of aspirin on von Willebrand factor-induced platelet aggregation

Thrombosis Research

Volumn 99, Issue 5, 2000, Pages 461-466

  Homoncik, Monika ^a   Jilma, Bernd ^a   Eichelberger, Beate ^a   Panzer, Simon ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Aspirin; Beads; Platelet aggregation; von Willebrand Factor

Indexed keywords

ACETYLSALICYLIC ACID; THROMBO ASS; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; DOSE RESPONSE; FEMALE; HUMAN; MALE; NORMAL HUMAN; PATIENT SELECTION; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

ADULT; ASPIRIN; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MICROSPHERES; PLATELET ADHESIVENESS; PLATELET AGGREGATION; PROSPECTIVE STUDIES; TIME FACTORS; VON WILLEBRAND FACTOR;

EID: 0034283493     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(00)00297-8     Document Type: Article

References (24)

1. Savage B, Shattil SJ, Ruggeri ZM. Modulation of platelet function through adhesion receptors. A dual role for glycoprotein IIb-IIIa (integrin alpha lib beta 3) mediated by fibrinogen and glycoprotein Ib-von Willebrand factor. J Biol Chem 1992;267:11300-6.
2. Meyer D, Girma JP. von Willebrand factor: structure and function. Thromb Haemost 1993; 70:99-104.
3. Gralnick HR, Kramer WS, McKeown LP, Garfinkkel L, Pinot A, Williams SB, Krutzsch H. Platelet adhesion at high shear rates: the roles of von Willebrand factor/GPIb and the beta 1 integrin alpha 2 beta 1. Thromb Res 1996; 81:113-9.
4. Serebruany VL, Gurbel PA, Shustov AR, Ohman EM, Topol EJ. Heterogeneity of platelet aggregation and major surface receptor expression in patients with acute myocardial infarction. Am Heart J 1998;136:398-405.
5. Minamoto Y, Hato T, Nakatani S, Fujita S. Detection of platelet adhesion/aggregation to immobilized ligands on microbeads by an aggregometer. Thromb Haemost 1996;76:1072-9.
6. Stewart MW, Etches WS, Boshkov LK, Mant MJ, Gordon PA, Shaw AR. Platelet activation by a novel solid-phase agonist: effects of vWF immobilized on polystyrene beads. Br J Haematol 1997;97:321-9.
7. Kroll MH, Harris TS, Moake JL, Handin RI, Schafer AI. von Willebrand factor binding to platelet GpIb initiates signals for platelet activation. J Clin Invest 1991;88:1568-73.
8. Patrono C. Prevention of myocardial infarction and stroke by aspirin: different mechanisms? Different dosage? Thromb Res 1998;92:S7-12.
9. De Caterina R, Boem A, Gazzetti P, Sicri R, Giannessi D, Ciabattoni G, Patrono C. Long-term maintenance of thromboxane inhibition by two different aspirin regimens in patients with unstable angina. Thromb Res 1990;60: 169-75.
10. Schror K. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis. Semin Thromb Hemost 1997;23:349-56.
11. Preston FE, Greaves M, Jackson CA, Stoddard CJ. Low-dose aspirin inhibits platelet and venous cyclo-oxygenase in man. Thromb Res 1982;27:477-84.
12. Patrono C, Ciabattoni G, Pinca E, Pugliese F, Castrucci G, DeSalvo A, Satta MA, Peskar BA. Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects. Thromb Res 1980;17:317-27.
13. Coller BS. Platelets and thrombolytic therapy. N Engl J Med 1990;322:33-42.
14. De Caterina R, Giannessi D, Gazzetti P, Bernini W. Inhibition of platelet aggregation and thromboxane B2 production during aspirin treatment: dependence on the dose of the aggregating agent. Thromb Res 1985;37:337-42.
15. Voss R, Geissler BS, Tillmanns H, Matthias FR. In vitro and ex vivo effects of aspirin in patients on a low-dose aspirin therapy. Thromb Res 1993;72:49-57.
16. Buchanan MR, Brister SJ. Individual variation in the effects of ASA on platelet function: implications for the use of ASA clinically. Can J Cardiol 1995;11:221-7.
17. Helgason CM, Bolin KM, Hoff JA, Winkler SR, Mangat A, Tortorice KL, Brace LD. Development of aspirin resistance in persons with previous ischemic stroke. Stroke 1994;25:2331-6.
18. Sathiropas P, Marbet GA, Sahaphong S, Duckert F. Detection of small inhibitory effects of acetylsalicylic acid (ASA) by platelet impedance aggregometry in whole blood. Thromb Res 1988;51:55-62.
19. Jilma B, Dirnberger E, Eichler HG, Matulla B, Schmetterer L, Kapiotis S, Speiser W, Wagner OF. Partial blockade of nitric oxide synthase blunts the exercise-induced increase of von Willebrand factor antigen and of factor VIII in man. Thromb Haemost 1997;78: 1268-71.
20. Farman N, Pradelles P, Bonvalet JP. PGE2, PGF2 alpha, 6-keto-PGF1 alpha, and TxB2 synthesis along the rabbit nephron. Am J Physiol 1987;252:F53-F59.
21. Pradelles P, Grassi J, Maclouf J. Enzyme immunoassays of eicosanoids using acetylcholinesterase. Methods Enzymol 1990;187:24-34.
22. FitzGerald GA, Oates JA, Hawiger J, Maas RL, Roberts LJ, Lawson JA, Brash AR. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest 1983;71:676-88.
23. Wong EC, Oblitas J, Leitman SF, Stroncek DF. Whole blood platelet von Willebrand reactivity in plateletpheresis donors: effects of age, gender and medications. Transfusion 1999; 39(Suppl):S38.
24. Bock M, De Haan J, Beck KH, Gutensohn K, Hertfelder HJ, Karger R, Heim MU, Beeser H, Weber D, Kretschmer V. Standardization of the PFA-100(R) platelet function test in 105 mmol/l buffered citrate: effect of gender, smoking, and oral contraceptives. Br J Haematol 1999;106:898-904.